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Abstract 
Osteoporosis is a skeleton disease characterized by a decrease in bone mass, disturbance 
of their microarchitecture and reduction of bone mineral density (BMD). Decreased bone quality 
is manifested by a higher risk of fractures, but bone pain and lowering of growth may occur 
earlier, although osteoporosis may occur asymptomatically before the fracture occurs. It is a 
disease of older people, affects 25 to 30% of postmenopausal women, while morbidity among 
men over 50 is around 8%. Bone tissue is subject to continuous remodeling as a result of 
resorption processes (release of minerals from the tissue) regulated by osteoclast activity and 
bone matrix construction by absorption of mineral components to maintain quality and bone mass 
resistance. In this study attention will be focused on the impact of vitamin supplementation on the 
development of osteoporosis 
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Introduction 
Osteoporosis is the result of disturbances in the metabolism of bone remodeling. 
Morbidity increases with age due to the decrease in the possibility of maintaining normal bone 
mass due to the aging of the body. Bone growth is the most intense in adolescence, it is 
significantly slowed after the age of 20, however, many studies sugested that bone mass can 
increases up to 35 years of age [1]. After reaching this age, the process of involution begins, in 
other words, the inevitable depletion of bone mass and a decrease in the quality of the skeleton. 
In postmenopausal women, this process accelerates. Studies mention, the annual loss of bone 
mass ranges from 1% to 3% per year, but in some cases may even exceed 3%. In men, the bone 
mass loss process is much slower. The risk factors for the development of osteoporosis is most in 
eldery age, in the group at risk of disease are women over 65 who are four times more likely and 
men who reached the age of 70. Lifestyle plays a big role in the prevention of osteoporosis,low 
low physical activity increases the risk of osteoporosis. The low BMI index correlates positively 
with the incidence of osteoporosis. The most important nutritional factors predisposing to 
osteoporosis are insufficient supply of calcium and vitamin D, inadequate supply of phosphorus 
and disturbed ratio of the amount of calcium to phosphorus consumed. Other factors are 
deficiencies of vitamin C and K and magnesium deficiency [2]. Too high a supply of protein and 
vitamin A increases the risk of osteoporosis. This review focuses on determining the effect of the 
supply of vitamins involved in bone metabolism, i.e. vitamin D, C and K on the prevention of 
osteoporosis, and the ability to inhibit the progression of bone resorption by introducing 
appropriate dietotherapy. The role of individual vitamins in the processes of bone formation and 
resorption will be discussed, followed by the results of studies assessing the effect of vitamins on 
parameters related to the quality of bone tissue and the risk of osteoporosis. 
MATERIALS AND METHODS 
Thirteen observational and experimental studies (including randomized clinical trials) 
from the years 2000-2019 are indicated in this review. The studies evaluating the effects of 
suplementation of only vitamins, which affected in bone metabolism (with the exception of the 
part dealing with vitamin D due to insufficient number of studies focused on calciferol nutritional 
interventions without additional calcium supplementation), the exclusion criteria was presence of 
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interventions with other nutrients or pharmaceuticals. Age of participants in all studies> 50 years, 
these were both healthy and suffering from osteoporosis and osteopenia. 
Vitamin D 
Vitamin D is definied as several fat-soluble compounds belonging to the group of 
steroids, which is responsible for the preservation of calcium homeostasis, phosphorus and 
magnesium, and for a number of other processes, e.g. immunomodulatory. The two most widely 
described in the literature substances are vitamin D2 (ergocalciferol) and vitamin D3 
(cholecalciferol), they differ from each other in the possition of the side chain. It is allowed to use 
the name calciferol in relation to both of them. The biologically active form of vitamin D is the 
1α,25-dihydroxyvalalferol, which is occur in result of  metabolism changes [3]. 
The daily requirement for calciferol for an adult is around 15 μg for both men and women. 
Vitamin D2 is eaten together with plant foods or fungi, while vitamin D2 is found in foods of 
animal origin. The richest sources of cholecalciferol are fatty fish, fish oils and eggs, and sources 
of ergocalciferol include yeast and some fungal species. Vitamin D is also found in fortified food, 
we can meet it in fat spreads. It is estimated that the daily intake of vitamin D with a diet is only 
2.5-5 μg / day, therefore supplementation of this vitamin is recommended from October to April 
[4]. However, calciferol is synthesized by the skin during exposure to the sun. In this way, 80% 
of the demand is covered. 
Absorption of vitamin D takes place in the gut, then connects to a specific carrier protein 
(gc globulin) and is taken up from the blood through the liver, followed by hydroxylation 
catalyzed by the enzyme 25-hydroxylase of vitamin D, because calciferol is not an active 
biological substance. In addition to the liver, hydroxylation also takes place in the kidneys, 
cartilages and intestines [5]. 1α, 25-dihydroxycalciferol has a multidirectional effect on the 
body's metabolism. It has an effect on the nervous system, stimulates the immune system by 
increasing the expression of genes encoding peptides with antibacterial activity [6]. In addition, 
vitamin inhibits the process of apoptosis and tumor cell angiogenesis. Vitamin D affects the 
absorption of calcium in the intestines. Under conditions of calcium deficiency, calciferol 
participates in the process of active calcium absorption, increasing its bioavailability. In 





Vitamin C is a water-soluble chemical compound from the group of polyhydric alcohols. 
Another name for this compound is ascorbic acid, its acid character is due to the presence of 
hydroxyl groups. It has strong antioxidant properties. The human body can't synthesize ascorbic 
acid by itself. The daily requirement for this vitamin is 75 mg for an adult woman and 90 mg for 
an adult male per day. Ascorbic acid is found in fruits and vegetables such as black currants, 
broccoli, spinach, lemon and orange [4]. Ascorbic acid plays a key role in the synthesis of 
collagen, affecting the activity of proteins responsible for the hydroxylation of proline. Vitamin C 
takes part in the synthesis of neurotransmitters, e.g. norepinephrine, also participates in the 
processes of building myelin sheaths, and protects the nervous system by removal of free 
radicals. In addition, ascorbic acid has a significant effect on the bone tissue metabolism. Affects 
the fate of osteoblasts and their proliferation. It plays a key role in creating the matrix of collagen 
tissue, and is active in the process of osteocalcogenesis [8].  
Vitamin K 
Vitamin K is actually a group of fat soluble biologically active substances derivatives of 
2-methyl-1,4-naphthoquinone. In the scientific literature, we can usually read about two chemical 
compounds - finochinon (K1) having a fityl residue in the third position, and menaquinone (K2), 
which distinguishes from the form K1 the presence of the isoprenoid side chain also in the third 
position. There is also a third form having no side chain - menadione (K3), which is a synthetic 
analogue [12]. The daily requirement for vitamin K for an adult male is at the level of 65 μg for 
an adult male and 55 μg for females [7]. Vitamin K must be supplied with the diet, sources of 
finochinon (K1) are vegetables such as: spinach, broccoli, kale, lettuce. Whereas menachinone 
(K2) is synthesized by human intestinal bacteria, it also occurs in products such as eggs, meat and 
milk and its products [13]. Absorption of vitamin K1 takes place in the small intestine, the 
absorption mechanism uses active transport, while the absorption of menaquinone requires no 
energy expenditure and takes place in the large intestine. Vitamin K is a fat-soluble substance, 
which is why chylomicrons and lipoproteins (ApoA, ApoB-48, ApoC and ApoE) are involved in 
its transport to the liver. Vitamin K leaves the liver in combination with VLDL, apolipoprotein 
B-100, C and E, and then penetrates osteoblasts due to the presence of receptors for lipoproteins 
such as LDLR and LRP1 [21]. The body is not able to store large amounts of vitamin K, hence it 
must be supplied on a regular basis with the diet. The body requies them to maintain normal 
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blood clotting through participation in hepatic synthesis of blood coagulation factors [9]. Vitamin 
K is a coenzyme for enzymatic reactions of protein synthesis regulating the synthesis of 
prothrombin, coagulation factor VII, IX, X. Vitamin K plays a very important role in maintaining 
bone strength, because it acts as a cofactor of gamma carboxylase - an activating enzyme 
dependent on vitamin K proteins such as OC, Gla protein, S protein and GAS6 protein. They are 
responsible, among others for the synthesis of new osteons, bone mineralization and bone 
calcium metabolism [11]. In addition, vitamin K mobilizes the formation of bone tissue, and 
inhibits bone resorption processes also through a mechanism unrelated to gamma carboxylase 
[12]. In addition, many studies have shown that the correct intake of vitamin K has a beneficial 
effect on bone mineral density (BMD). 
RESULTS 
Vitamin D 
Calciferol plays a important role in the phosphate-calcium economy. Vitamin D 
deficiency may contribute to the deterioration of skeletal structure by reducing the absorption of 
calcium in the intestines [13].  
 
Table 1. Results of vitamin D intervention own source [16] 
Authors n Group Method Time Results 
Robin M Daly 
and others 
2009 [15] 
167 Health men in 
age >50 
Fortified milk 
(1000 mg Ca2++ 
800 IU D3/day) 






367 Women at age 
>60 




4 years Slight decrease in bone 
resorption, slower 
reduction in BMD, 
prevention of secondary 
hyperparathyroidism in the 
vitamin D group 
Grados F. and 
others 
2003 [18] 
192 Women at age 
>65 




1 year Increase of BMD, 
decrease NTX, CTX, ALP 
in supplementation of 





9605 Males and 






4 years 16% fewer fractures in the 
group included in the 
supplementation program 




It is presumed that the therapeutic effect of vitamin D supplementation is poorly 
noticeable, and the benefits of optimal supply are closely related to the improvement of calcium 
absorption [14]. For this reason, most interventions are based on supplementation of both vitamin 
D and calcium. Low levels of vitamin D are associated with a higher incidence of osteoporosis 
[15]. 
A number of studies have demonstrated the effectiveness of vitamin D supplementation in 
combination with calcium in the treatment of osteoporosis. 
Vitamin C 
Table. 2 Results of vitamin C intervention own source [16] 
Authors n Group Method Time Results 
Sahni S. 
2009 [20] 




vitamin C (average 
intake 313 mg/day) 
17 years Significantly less 
fractures in the group 





3047 Males and 
females in age 
>50 
Assessment of intake 
of vitamin C in 
traditional diet 
4 years Negative correlation 
between the risk of 
osteoporosis and the 




187 Females in 
postmenopaus
al age 
Assessment of intake 
of vitamin C in 
traditional diet 
4 years Significantly slower 
drop in BMD in the 
group with high intake 
of vitamin C compared 
to the low supply group 
Kim YA. and 
others 
2009 [23] 
1196 Females in 
postmenopaus
al age, and 
females with 
osteoporosis 
Assessment of vitamin 
C intake, which uses 
24 hours intake 
method 
2 years Positive correlation 
between vitamin C 
intake and BMD, lower 
intake of vitamin C in 
the osteoporotic group 
 
An adequate supply of ascorbic acid reduces the risk of fractures in the elderly population 
[20]. The higher intake of vitamin C in the daily food ration reduces the risk of developing 
osteoporosis. The lower concentration of vitamin C in plasma is associated with a decrease in 
BMD [21] [22]. Adequate supply of ascorbic acid promotes the preservation of bone mass and 
bone mineral density [23]. The observed correlations are the result of the presence of ascorbic 
acid in many processes of tissue synthesis, and antioxidant activity that protects tissues from the 





Is well known fact, vitamin K has a significant effect on bone tissue metabolism. Its 
proper supply promotes the preservation of beneficial bone mineral density, inhibits the bone 
resorption process and stimulates the synthesis processes of new tissues. 
 
Table 3. Results of vitamin K intervention own source [16] 
Authors n Group Method Time Results 
Yasui T and 
others 
2006 [24] 






K2(45 mg/day) i 
D3(0,75 
mcg/day) 
1 year Decrease of ucOC in 
bouth groups, 
decrease of OC and 
BALP in group with 











4 years Decrease of ucOC 
and level ofOC, no 












2 years Increase %BMD in 
18-24 month of 
observations 
Koitaya N. and 
others 
2013 [28] 















3 years Significantly lower 
decrease of body 
heitght in group MK-
7 
UcOC – Correlation of Undercarboxylated Osteocalcin; OC – Osteocalcin; BALP – 
Bone-specific Alkaline Phosphatase; CTX – C-terminal Telopeptide; BMD – Bone Mineral 
Density 
 
Studies from 2002-2013 investigating the effectiveness of vitamin K supplementation 
have shown that such intervention may have a positive effect on bone tissue condition. Yasui T 
and others assessed the bone resorption rates and obtained a decrease in the ucOC index in the 
vitamin K group [24]. Other studies point to the inverse correlation between ucOC and BMD 
[25]. Cheung et al. in its 4-year study also showed the effect of vitamin K supplementation on the 
decrease in ucOC and OC [26]. The prerequisites for affecting bone mineral density (BMD) are 
unclear. In the study of a group of women suffering from osteoporosis or osteopenia, an increase 
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in BMD was observed after 18 months of supplementation with vitamin K (MK-4) [27], 
however, Koitaya N. and others in 2013 found no differences in BMD in relation to MK-4 
supplementation [28].  Decrease in body height is an indicator of bone loss and development of 
osteoporosis, it is also positively correlated with the frequency of bone fractures. Knapen's MHJ 





There are mentions about the influence of the correct supply of vitamins and minerals in 
adolescence (during the predominance of bone formation processes on resorption) to a decrease 
in the risk of osteoporosis. 2% higher skeletal mass in adolescente correlates with a 20% lower 
risk of osteoporosis in eldery age [30]. The diet of many polish people is characterized by 
inadequate supply of vitamins and minerals. In addition which in combination with high 
consumption of alcohol and tobacco increases the risk of bone disease. Data indicate a deficit in 
vitamin D in 89% of young women in the winter [31], and a significant part of the Polish 
population also has too low a level of vitamin C intake [32]. Increase people's awareness of the 
impact of nutrition and lifestyle on the risk of civilization diseases is necessary. Greater 
awareness of health threats will favorably influence the development of eating habits. Parents 
education is very important because the mother's and father's eating habits have a tremendous 
impact on shaping their children's lifestyle. Studies included in this review prove the 
effectiveness of vitamin supplementation in the treatment of osteoporosis. The population-
program of vitamin D supplementation showed a positive effect for bone quality in eldery people, 
and contributed to decrease amount of fractures [22]. Running more similar programs should 
reduce morbidity of osteoporosis. 
CONCLUSIONS 
Correct level of vitamin D, C and K intake have a beneficial effect for quality of bone 
tissue. Supplementation with calcium and calciferol has a positive effect on bone mineral density, 
lowers bone resorption rates and reduces the risk of fractures. The therapeutic effect is noticeable 
in healthy people as well as those suffering from osteoporosis. The intake of vitamin D and 
calcium at an appropriate level throughout life is an important factor in the prevention of 
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osteoporosis. Studies showed a significant relationship between the intake of vitamin C and the 
condition of bone tissue. Intake of vitamin C should be controlled during osteoporosis treatment. 
Most studies on the influence of vitamin K on the development of osteoporosis indicate an 
inverse correlation between the adequate supply of vitamin K and the markers of osteoporosis 
development. Vitamin K slows down the disease and shows effectiveness in the prevention of 
bone disease. The exact mechanism of the effect of vitamins on bone metabolism has not yet 
been recognized. Further investigations are needed. 
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